About UDX
UDX is a company based in Sevilla (Spain) founded in 2012.. UDX has raised $105.01 million across 7 funding rounds from investors including Olympus, Quest Diagnostics and European Investment Bank. UDX offers products and services including Signal C® and Cancer Platform. UDX operates in a competitive market with competitors including Delfi Diagnostics, Earli, Mirxes, Foresight Diagnostics and Haystack Oncology, among others.
- Headquarter Sevilla, Spain
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$105.01 M (USD)
in 7 rounds
-
Latest Funding Round
$35.01 M (USD), Series C
Jan 22, 2026
-
Investors
Olympus
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of UDX
UDX offers a comprehensive portfolio of products and services, including Signal C® and Cancer Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Blood test for early detection of colorectal cancer.
Minimally-invasive blood-based solutions for early cancer identification.
Unlock access to complete
Unlock access to complete
Funding Insights of UDX
UDX has successfully raised a total of $105.01M across 7 strategic funding rounds. The most recent funding activity was a Series C round of $35.01 million completed in January 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series C — $35.0M
- First Round First Round
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2026 | Amount | Series C - UDX | Valuation |
investors |
|
| Feb, 2025 | Amount | Debt – Conventional - UDX | Valuation |
investors |
|
| Aug, 2024 | Amount | Series B - UDX | Valuation | Quest Diagnostics , Olympus |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in UDX
UDX has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Olympus, Quest Diagnostics and European Investment Bank. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Finance and advisory services for infrastructure projects are provided.
|
Founded Year | Domain | Location | |
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by UDX
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - UDX
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Udx Comparisons
Competitors of UDX
UDX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Delfi Diagnostics, Earli, Mirxes, Foresight Diagnostics and Haystack Oncology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of DNA sequencing for cancer detection
|
|
| domain | founded_year | HQ Location |
Early cancer detection tests are developed using synthetic biomarkers.
|
|
| domain | founded_year | HQ Location |
miRNA-based tests for cancer detection are developed.
|
|
| domain | founded_year | HQ Location |
Minimally invasive liquid biopsy tests for cancer detection are developed.
|
|
| domain | founded_year | HQ Location |
Personalized cancer diagnostic tests are provided for minimal residual disease.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Udx
Frequently Asked Questions about UDX
When was UDX founded?
UDX was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Where is UDX located?
UDX is headquartered in Sevilla, Spain. It is registered at Sevilla, Andalucia, Spain.
Is UDX a funded company?
UDX is a funded company, having raised a total of $105.01M across 7 funding rounds to date.
What does UDX do?
Founded in 2012 in Seville, Spain, the company operates in the biotechnology sector, focusing on non-invasive diagnostics. Blood samples from patients are analyzed using metabolomics to identify early indicators of cancer. Screening tests have been developed for colorectal, lung, and breast cancers, enabling detection through routine blood draws without invasive procedures. Operations center on advancing these diagnostic tools for clinical use.
Who are the top competitors of UDX?
UDX's top competitors include Delfi Diagnostics, Earli and Mirxes.
What products or services does UDX offer?
UDX offers Signal C® and Cancer Platform.
Who are UDX's investors?
UDX has 6 investors. Key investors include Olympus, Quest Diagnostics, European Investment Bank, European Union, and EIC Fund.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.